Soligenix Investor Relations Material
Latest events
Q1 2025
8 May, 2025
Q4 2024
21 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Soligenix Inc
Access all reports
Soligenix Inc is a U.S.-based biopharmaceutical company focused on developing and commercializing treatments for rare diseases and biodefense indications. The company works on therapies for inflammatory conditions, oncology, and infectious diseases, with both proprietary drug candidates and government-supported programs. The company is headquartered in Princeton, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
Ticker symbol
SNGX
Country
🇺🇸 United States